Growth Metrics

Dna X (SONM) Gains from Investment Securities (2018 - 2025)

Dna X's Gains from Investment Securities history spans 8 years, with the latest figure at -$480000.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at -$480000.0 for Q4 2025, down 214.01% from a year ago — trailing twelve months through Dec 2025 was -$87000.0 (down 123.32% YoY), and the annual figure for FY2025 was $34883.0, up 3048.29%.
  • Gains from Investment Securities for Q4 2025 was -$480000.0 at Dna X, down from $36360.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $5.8 million in Q2 2023 to a low of -$480000.0 in Q4 2025.
  • The 5-year median for Gains from Investment Securities is $49000.0 (2021), against an average of $458456.8.
  • The sharpest move saw Gains from Investment Securities skyrocketed 89505.49% in 2023, then plummeted 233.33% in 2024.
  • Year by year, Gains from Investment Securities stood at $42000.0 in 2021, then surged by 569.05% to $281000.0 in 2022, then tumbled by 109.61% to -$27000.0 in 2023, then surged by 1659.26% to $421000.0 in 2024, then crashed by 214.01% to -$480000.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$480000.0, $36360.0, and $675779.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.